BioPharmSignal logoBioPharmSignal

Biotech News

AtriCure Reports Third Quarter 2026 Financial Results

AtriCure (ATRC)AtriCureEarnings

Third Quarter 2026 worldwide revenue of $154.5 million, an increase of 15.0% year over year Profitability expansion in the Third Quarter 2026, with net income of $4.1 million and adjusted EBITDA of $26.8 million MASON, Ohio --(BUSINESS WIRE)--Nov. 3, 2026-- AtriCure, Inc.

Related news

ATRCAtriCure2026-10-13 12:00 EST

AtriCure to Announce Third Quarter 2026 Financial Results

TMCITreace Medical Concepts2026-11-06 12:05 EST

Treace Medical Concepts Reports Third Quarter 2026 Financial Results

CVRXCVRx2026-11-05 21:05 EST

CVRx Reports Third Quarter 2026 Financial and Operating Results

AORTArtivion2026-11-05 21:05 EST

Artivion Reports Third Quarter 2026 Financial Results

PLSEPulse Biosciences2026-11-05 21:05 EST

Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial Results

APYXApyx Medical2026-11-05 12:00 EST

Apyx Medical Corporation Reports Third Quarter 2026 Financial Results

SGHTSight Sciences2026-11-04 21:05 EST

Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance

ADPTAdaptive Biotechnologies2026-11-04 21:05 EST

Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results

PRCTPROCEPT BioRobotics2026-11-04 21:05 EST

PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance

ACHCAcadia Healthcare2026-11-04 21:05 EST

Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance

View all latest news

AtriCure

Atrial Fibrillation Surgery AtriCure develops medical devices and procedures for the surgical treatment of atrial fibrillation. Its products are used by cardiac surgeons to create controlled lesions that interrupt abnormal electrical pathways and restore a more regular heart rhythm. Ablation Technologies The Isolator Synergy Ablation...

Recent company news

ATRCAtriCure2026-11-03 21:01 EST

AtriCure Reports Third Quarter 2026 Financial Results

ATRCAtriCure2026-10-26 12:00 EST

AtriCure to Participate at Upcoming Investor Conferences

ATRCAtriCure2026-10-13 12:00 EST

AtriCure to Announce Third Quarter 2026 Financial Results

ATRCAtriCure2026-08-25 12:00 EST

AtriCure to Participate in the 2026 Wells Fargo Health Care Conference

ATRCAtriCure2026-07-27 12:00 EST

AtriCure to Participate at Upcoming Investor Conferences

Stock data

Close
61.28 USD
Market cap
1.31B USD
Exchange
NASDAQ
Sector
MedTech
Location
United States